Oncogene

Papers
(The TQCC of Oncogene is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Identification of novel germline mutations in FUT7 and EXT1 linked with hereditary multiple exostoses189
SOX10 deficiency-mediated LAMB3 upregulation determines the invasiveness of MAPKi-resistant melanoma168
Correction: Regulation of cancer stem cell activity by thyroid hormone receptor β165
Clonal populations of a human TNBC model display significant functional heterogeneity and divergent growth dynamics in distinct contexts139
Deciphering glioma epitranscriptome: focus on RNA modifications138
USP5 deubiquitinates and stabilizes IMPDH2, to promote hepatocellular carcinoma progression132
Correction to: Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential113
Correction: S100A3 a partner protein regulating the stability/activity of RARα and PML-RARα in cellular models of breast/lung cancer and acute myeloid leukemia113
Structure and function of MuvB complexes110
SKAP2 suppresses inflammation-mediated tumorigenesis by regulating SHP-1 and SHP-2107
Correction: Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer105
Correction: Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor95
SCD5-dependent inhibition of SPARC secretion hampers metastatic spreading and favors host immunity in a TNBC murine model92
AMPK-deficiency forces metformin-challenged cancer cells to switch from carbohydrate metabolism to ketogenesis to support energy metabolism88
A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML)86
Retraction Note: CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells86
Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion85
MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex81
Estrogen-related receptor alpha promotes thyroid tumor cell survival via a tumor subtype-specific regulation of target gene networks79
GREB1 isoform 4 is specifically transcribed by MITF and required for melanoma proliferation77
MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells77
HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin75
ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma72
ALDH1A3 is the switch that determines the balance of ALDH+ and CD24−CD44+ cancer stem cells, EMT-MET, and glucose metabolism in breast cancer72
H3K9me3 represses G6PD expression to suppress the pentose phosphate pathway and ROS production to promote human mesothelioma growth72
BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer69
Hypoxia induces chemoresistance to proteasome inhibitors through orchestrating deSUMOylation and ubiquitination of SRC-3 in multiple myeloma66
A comprehensive analysis of LMO2 pathogenic regulatory profile during T-lineage development and leukemic transformation66
The hTERT-p50 homodimer inhibits PLEKHA7 expression to promote gastric cancer invasion and metastasis65
Mapping the breast tumor microenvironment: proximity analysis reveals spatial relationships between macrophage subtypes and metastasis-initiating cancer cells65
tRF-33-P4R8YP9LON4VDP inhibits gastric cancer progression via modulating STAT3 signaling pathway in an AGO2-dependent manner64
Notch signaling regulates a metabolic switch through inhibiting PGC-1α and mitochondrial biogenesis in dedifferentiated liposarcoma64
Targeting STING elicits GSDMD-dependent pyroptosis and boosts anti-tumor immunity in renal cell carcinoma63
LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer63
Gamma-glutamyltransferase 7 suppresses gastric cancer by cooperating with RAB7 to induce mitophagy63
Nup54-induced CARM1 nuclear importation promotes gastric cancer cell proliferation and tumorigenesis through transcriptional activation and methylation of Notch262
Downregulation of HINFP induces senescence-associated secretory phenotype to promote metastasis in a non-cell-autonomous manner in bladder cancer62
Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity61
RBMS3-loss impedes TRIM21-induced ubiquitination of ANGPT2 in an RNA-independent manner and drives sorafenib resistance in hepatocellular carcinoma60
METTL3-mediated N6-methyladenosine modification of STAT5A promotes gastric cancer progression by regulating KLF458
LncRNA XIST regulates breast cancer stem cells by activating proinflammatory IL-6/STAT3 signaling57
Correction: Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis56
Spatiotemporal view of malignant histogenesis and macroevolution via formation of polyploid giant cancer cells56
Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis56
The protection of UCK2 protein stability by GART maintains pyrimidine salvage synthesis for HCC growth under glucose limitation54
Chromatin-associated OGT promotes the malignant progression of hepatocellular carcinoma by activating ZNF26354
Induction of IL6/STAT3-dependent TRAIL expression that contributes to the therapeutic efficacy of osimertinib in EGFR mutant NSCLC cells54
PRSS23-eIF4E-c-Myc axis promotes gastric tumorigenesis and progression53
STT3A-mediated viral N-glycosylation underlies the tumor selectivity of oncolytic virus M152
CEMIP, a novel adaptor protein of OGT, promotes colorectal cancer metastasis through glutamine metabolic reprogramming via reciprocal regulation of β-catenin51
Application of machine learning to large in-vitro databases to identify cancer cell characteristics: telomerase reverse transcriptase (TERT) expression50
CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype50
Correction to: EphA2–YES1–ANXA2 pathway promotes gastric cancer progression and metastasis49
Correction: Exosomal circCARM1 from spheroids reprograms cell metabolism by regulating PFKFB2 in breast cancer49
RNA-sequencing predicts a role of androgen receptor and aldehyde dehydrogenase 1A1 in osteosarcoma lung metastases49
Correction: MZF1 mediates oncogene-induced senescence by promoting the transcription of p16INK4A49
RIOK1 mediates p53 degradation and radioresistance in colorectal cancer through phosphorylation of G3BP249
Inhibition of multiple CDKs potentiates colon cancer chemotherapy via p73-mediated DR5 induction48
AGO4 suppresses tumor growth by modulating autophagy and apoptosis via enhancing TRIM21-mediated ubiquitination of GRP78 in a p53-independent manner48
Ornithine decarboxylase (ODC1) gene variant (rs2302615) is associated with gastric cancer independently of Helicobacter pylori CagA serostatus48
Correction: Editorial Expression of Concern: Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer47
Correction: MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP147
Revealing the tumor suppressive sequence within KL1 domain of the hormone Klotho45
Correction to: Ionizing radiation-induced NF-κB activation requires PARP-1 function to confer radioresistance45
Retraction Note: Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis45
Editorial Expression of Concern: Role of BRCA1 in heat shock response45
Recent insights into the causes and consequences of chromosome mis-segregation45
Correction to: Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH145
The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival44
Alternative splicing in prostate cancer progression and therapeutic resistance44
MASTL regulates EGFR signaling to impact pancreatic cancer progression44
Pancreatic ductal adenocarcinoma induces neural injury that promotes a transcriptomic and functional repair signature by peripheral neuroglia44
Single-cell multiomics reveals a gene regulatory circuit driving leukemia cell differentiation44
The platelet pannexin 1-IL-1β axis orchestrates pancreatic ductal adenocarcinoma invasion and metastasis43
FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis43
RB loss determines selective resistance and novel vulnerabilities in ER-positive breast cancer models42
Crosstalk between endothelial progenitor cells and HCC through periostin/CCL2/CD36 supports formation of the pro-metastatic microenvironment in HCC42
CircKDM4B suppresses breast cancer progression via the miR-675/NEDD4L axis42
AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors41
Transferrin receptor 1 promotes the fibroblast growth factor receptor-mediated oncogenic potential of diffused-type gastric cancer41
Delactylase effects of SIRT1 on a positive feedback loop involving the H19-glycolysis-histone lactylation in gastric cancer41
ROS production by mitochondria: function or dysfunction?40
The lncRNA ST18-AS1 suppresses pancreatic cancer progression by enhancing ST18 mRNA stability through anchoring FUS in the cytoplasm40
METTL3 promotes cellular senescence of colorectal cancer via modulation of CDKN2B transcription and mRNA stability40
Stabilization of MOF (KAT8) by USP10 promotes esophageal squamous cell carcinoma proliferation and metastasis through epigenetic activation of ANXA2/Wnt signaling40
C4orf19 inhibits colorectal cancer cell proliferation by competitively binding to Keap1 with TRIM25 via the USP17/Elk-1/CDK6 axis40
Calcineurin inactivation inhibits pyruvate dehydrogenase complex activity and induces the Warburg effect39
SOX9 drives KRAS-induced lung adenocarcinoma progression and suppresses anti-tumor immunity39
YBX1 promotes 5-Fluorouracil resistance in gastric cancer via m5C-dependent ATG9A mRNA stabilization through autophagy39
Functional screening reveals HORMAD1-driven gene dependencies associated with translesion synthesis and replication stress tolerance39
Phosphorylation of USP27X by PIM2 promotes glycolysis and breast cancer progression via deubiquitylation of MYC39
Tumor cell-derived ANGPTL2 promotes β-catenin-driven intestinal tumorigenesis39
Enhanced anti-cancer efficacy of arginine deaminase expressed by tumor-seeking Salmonella Gallinarum38
Correction to: Long non-coding RNA KRT19P3 suppresses proliferation and metastasis through COPS7A-mediated NF-κB pathway in gastric cancer38
Mesenchymal stromal cells confer breast cancer doxorubicin resistance by producing hyaluronan38
Therapeutic targeting the oncogenic driver EWSR1::FLI1 in Ewing sarcoma through inhibition of the FACT complex38
Matriptase-2/NR4A3 axis switches TGF-β action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis38
Cyclin E1 overexpression sensitizes ovarian cancer cells to WEE1 and PLK1 inhibition38
Correction: ROR1-targeting switchable CAR-T cells for cancer therapy38
Correction: NFκB activation by hypoxic small extracellular vesicles drives oncogenic reprogramming in a breast cancer microenvironment38
Correction: PLK1 inhibition selectively induces apoptosis in ARID1A deficient cells through uncoupling of oxygen consumption from ATP production38
SIRT7: a novel molecular target for personalized cancer treatment?37
E7-mediated repression of miR-203 promotes LASP1-dependent proliferation in HPV-positive cervical cancer37
Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia37
Ac4C modification of lncRNA SIMALR promotes nasopharyngeal carcinoma progression through activating eEF1A2 to facilitate ITGB4/ITGA6 translation37
RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition37
Activation of NFAT by HGF and IGF-1 via ARF6 and its effector ASAP1 promotes uveal melanoma metastasis37
Tumor innervation is triggered by endoplasmic reticulum stress37
Feedback activation of EGFR/wild-type RAS signaling axis limits KRASG12D inhibitor efficacy in KRASG12D-mutated colorectal cancer37
Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma36
The influence of endothelial metabolic reprogramming on the tumor microenvironment36
Engineering prostate cancer in vitro: what does it take?36
Decitabine enhances targeting of AML cells by NY-ESO-1-specific TCR-T cells and promotes the maintenance of effector function and the memory phenotype36
Correction: Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours36
PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer36
The sodium channel subunit SCNN1B suppresses colorectal cancer via suppression of active c-Raf and MAPK signaling cascade35
OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer35
MicroRNAs: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances35
Inactivation of EGLN3 hydroxylase facilitates Erk3 degradation via autophagy and impedes lung cancer growth35
Tumor-mesothelium HOXA11-PDGF BB/TGF β1-miR-181a-5p-Egr1 feedforward amplifier circuity propels mesothelial fibrosis and peritoneal metastasis of gastric cancer35
BRD4 regulates PAI-1 expression in tumor-associated macrophages to drive chemoresistance in colorectal cancer35
OLFM4 deficiency delays the progression of colitis to colorectal cancer by abrogating PMN-MDSCs recruitment35
Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma34
Correction: Loss-of-function mutations of SOX17 lead to YAP/TEAD activation-dependent malignant transformation in endometrial cancer34
The kinesin KIF20A promotes progression to castration-resistant prostate cancer through autocrine activation of the androgen receptor34
Correction: Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi’s sarcoma development34
Correction to: Smad7 is inactivated through a direct physical interaction with the LIM protein Hic-5/ARA5534
Correction: Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma34
Inactivation of kindlin-3 increases human melanoma aggressiveness through the collagen-activated tyrosine kinase receptor DDR134
O-GlcNAcylation of E3 ubiquitin ligase SKP2 promotes hepatocellular carcinoma proliferation34
The scaffold protein IQGAP1 links heat-induced stress signals to alternative splicing regulation in gastric cancer cells34
Correction: IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma33
Thioredoxin reductase is a major regulator of metabolism in leukemia cells33
Retraction Note: Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor33
Molecular explorations of cancer biology and therapeutics at PDB-10133
miR-22 promotes stem cell traits via activating Wnt/β-catenin signaling in cutaneous squamous cell carcinoma33
Correction: The ELF3-regulated lncRNA UBE2CP3 is over-stabilized by RNA–RNA interactions and drives gastric cancer metastasis via miR-138-5p/ITGA2 axis33
Correction: LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway33
Retraction Note: Hypoxia-associated p38 mitogen-activated protein kinase-mediated androgen receptor activation and increased HIF-1α levels contribute to emergence of an aggressive phenotype in prostat33
Phosphorylation of FOXK2 at Thr13 and Ser30 by PDK2 sustains glycolysis through a positive feedback manner in ovarian cancer32
Single-cell landscape of undifferentiated pleomorphic sarcoma32
Zinc ions activate AKT and promote prostate cancer cell proliferation via disrupting AKT intramolecular interaction32
Correction to: Adaptor SH3BGRL promotes breast cancer metastasis through PFN1 degradation by translational STUB1 upregulation32
Shallow whole genome re-sequencing to precisely predict benefit from PARP inhibitor32
Lysine metabolism is a novel metabolic tumor suppressor pathway in breast cancer32
Correction: Combination strategies with PARP inhibitors in BRCA-mutated triple-negative breast cancer: overcoming resistance mechanisms31
USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer31
Targeting SLP2-mediated lipid metabolism reprograming restricts proliferation and metastasis of hepatocellular carcinoma and promotes sensitivity to Lenvatinib31
CircVPS8 promotes the malignant phenotype and inhibits ferroptosis of glioma stem cells by acting as a scaffold for MKRN1, SOX15 and HNF4A31
The role of miR-92b-3p in notch signaling and monitoring of oral squamous cell carcinoma31
A proof of concept for targeting the PrPC - Amyloid β peptide interaction in basal prostate cancer and mesenchymal colon cancer31
HJURP is recruited to double-strand break sites and facilitates DNA repair by promoting chromatin reorganization31
sEV-mediated intercellular transformation from MGAT4AHigh to MGAT4ALow tumor cells via the HOTAIRM1/miR-196b-5p axis promotes apoptosis resistance in CTCL31
HOTAIR/Sp1/miR-199a critically regulates cancer stemness and malignant progression of cutaneous squamous cell carcinoma31
PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT331
Celastrol recruits UBE3A to recognize and degrade the DNA binding domain of steroid receptors31
LncRNA PVT-1 promotes osteosarcoma cancer stem-like properties through direct interaction with TRIM28 and TSC2 ubiquitination31
PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma31
Hesperadin suppresses pancreatic cancer through ATF4/GADD45A axis at nanomolar concentrations31
A multi-faceted discovery strategy identifies functional antibodies binding to cysteine-rich domain 1 of hDKK1 for cancer immunotherapy via Wnt non-canonical pathway30
The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulation30
Chemerin enhances mesenchymal features of glioblastoma by establishing autocrine and paracrine networks in a CMKLR1-dependent manner30
circIPO7 dissociates caprin-1 from ribosomes and inhibits gastric cancer cell proliferation by suppressing EGFR and mTOR30
Selective inhibition of CDK9 in triple negative breast cancer30
Editorial Expression of Concern: Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress30
The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review29
Long non-coding RNA-MIR181A1HG acts as an oncogene and contributes to invasion and metastasis in gastric cancer29
Engineered targeting OIP5 sensitizes bladder cancer to chemotherapy resistance via TRIP12-PPP1CB-YBX1 axis29
Correction: Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma29
Editorial Expression of Concern: Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer29
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer29
ARHGAP–RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer29
Clustering single-cell RNA sequencing data via iterative smoothing and self-supervised discriminative embedding29
Nuclear FGFR1 promotes pancreatic stellate cell-driven invasion through up-regulation of Neuregulin 129
Retraction Note: Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer29
CBX3 accelerates the malignant progression of glioblastoma multiforme by stabilizing EGFR expression29
Editorial Expression of Concern: Gene expression profile by blocking the SYT-SSX fusion gene in synovial sarcoma cells. Identification of XRCC4 as a putative SYT-SSX target gene29
The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a review29
The proteomic characterization of the peritumor microenvironment in human hepatocellular carcinoma29
Alcohol-driven metabolic reprogramming promotes development of RORγt-deficient thymic lymphoma29
Retraction Note: E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage29
Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy29
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers28
JAK2/ULK1 axis promotes cervical cancer progression by autophagy induction and SRPK1 phosphorylation28
Origin and Evolution of RAS Membrane Targeting28
Integrative metabolomic characterization identifies plasma metabolomic signature in the diagnosis of papillary thyroid cancer28
GNAO1 overexpression promotes neural differentiation of glioma stem-like cells and reduces tumorigenicity through TRIM21/CREB/HES1 axis28
Irreversible JNK blockade overcomes PD-L1-mediated resistance to chemotherapy in colorectal cancer28
Ubiquitin and ubiquitin-like proteins in HPV-driven carcinogenesis28
Protein disulfide isomerase-enriched extracellular vesicles from bladder cancer cells support tumor survival and malignant transformation in the bladder28
Critical requirement of SOS1 RAS-GEF function for mitochondrial dynamics, metabolism, and redox homeostasis28
PP2A-B55: substrates and regulators in the control of cellular functions28
Inner nuclear membrane protein TMEM201 promotes breast cancer metastasis by positive regulating TGFβ signaling28
PELO facilitates PLK1-induced the ubiquitination and degradation of Smad4 and promotes the progression of prostate cancer28
Suppression of mutant Kirsten-RAS (KRASG12D)-driven pancreatic carcinogenesis by dual-specificity MAP kinase phosphatases 5 and 628
Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma28
DMT1-dependent endosome-mitochondria interactions regulate mitochondrial iron translocation and metastatic outgrowth27
TTPAL promotes gastric tumorigenesis by directly targeting NNMT to activate PI3K/AKT signaling27
The role of α-klotho in human cancer: molecular and clinical aspects27
Single-cell RNA-seq recognized the initiator of epithelial ovarian cancer recurrence27
VprBP/DCAF1 regulates p53 function and stability through site-specific phosphorylation27
WTAP-mediated m6A methylation of PHF19 facilitates cell cycle progression by remodeling the accessible chromatin landscape in t(8;21) AML27
Regulation of a progenitor gene program by SOX4 is essential for mammary tumor proliferation27
CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis27
ScRNA-seq of gastric cancer tissues reveals differences in the immune microenvironment of primary tumors and metastases27
Appearance of tuft cells during prostate cancer progression27
Importin-alpha transports Norrin to the nucleus to promote proliferation and Notch signaling in glioblastoma stem cells27
How artificial intelligence might disrupt diagnostics in hematology in the near future27
Targeting RBM39 suppresses tumor growth and sensitizes osteosarcoma cells to cisplatin26
Blockade of CHRNB2 signaling with a therapeutic monoclonal antibody attenuates the aggressiveness of gastric cancer cells26
DCision-making in tumors governs T cell anti-tumor immunity26
RNF126-mediated ubiquitination of FSP1 affects its subcellular localization and ferroptosis26
M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription26
Correction: Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma26
Neuropilin-2 promotes lineage plasticity and progression to neuroendocrine prostate cancer26
A novel integrated approach to predicting cancer immunotherapy efficacy26
Loss of deubiquitylase USP2 triggers development of glioblastoma via TGF-β signaling26
Epigenetics behind tumor immunology: a mini review26
GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma26
FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis26
RETRACTED ARTICLE: Targeting HIF-1α/NOTCH1 pathway eliminates CD44+ cancer stem-like cell phenotypes, malignancy, and resistance to therapy in head and neck squamous cell carcinoma26
A novel lncRNA MTAR1 promotes cancer development through IGF2BPs mediated post-transcriptional regulation of c-MYC26
The landscape and biological relevance of aberrant alternative splicing events in esophageal squamous cell carcinoma26
Amyloid-like p53 as prognostic biomarker in serous ovarian cancer—a study of the OVCAD consortium25
GPER-mediated stabilization of HIF-1α contributes to upregulated aerobic glycolysis in tamoxifen-resistant cells25
Retraction Note: MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer25
Nuclear translocation of Gasdermin D sensitizes colorectal cancer to chemotherapy in a pyroptosis-independent manner25
EphA2 regulates vascular permeability and prostate cancer metastasis via modulation of cell junction protein phosphorylation25
SMARCE1 promotes neuroblastoma tumorigenesis through assisting MYCN-mediated transcriptional activation25
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer25
Subsets of cancer cells expressing CX3CR1 are endowed with metastasis-initiating properties and resistance to chemotherapy25
Persistent organic pollutants promote aggressiveness in prostate cancer25
GDP-mannose 4,6-dehydratase is a key driver of MYCN-amplified neuroblastoma core fucosylation and tumorigenesis25
Correction: TSPAN6 is a suppressor of Ras-driven cancer25
Correction: Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program25
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer25
BCL-2 isoform β promotes angiogenesis by TRiC-mediated upregulation of VEGF-A in lymphoma25
Circulating extracellular vesicles protein expression for early prediction of platinum-resistance in high-grade serous ovarian cancer25
IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma24
Viral and cellular oncogenes promote immune evasion24
p53 modulates kinase inhibitor resistance and lineage plasticity in NF1-related MPNSTs24
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis24
TMIGD1: Emerging functions of a tumor supressor and adhesion receptor24
PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma24
CircUSP1 as a novel marker promotes gastric cancer progression via stabilizing HuR to upregulate USP1 and Vimentin24
Cancer-associated fibroblasts promote EGFR-TKI resistance via the CTHRC1/glycolysis/H3K18la positive feedback loop24
The E3 ligase COP1 promotes ERα signaling and suppresses EMT in breast cancer24
Correction: Notch3-regulated microRNAs impair CXCR4-dependent maturation of thymocytes allowing maintenance and progression of T-ALL24
JMJD6 in tumor-associated macrophage regulates macrophage polarization and cancer progression via STAT3/IL-10 axis24
β-Catenin-CCL2 feedback loop mediates crosstalk between cancer cells and macrophages that regulates breast cancer stem cells24
0.20063185691833